Advarra today announced the acquisition of Longboat, a provider of clinical trial technologies focused on site training, protocol compliance, and patient engagement. The addition of Longboat, headquartered in Dublin, Ireland, enables Advarra to offer a broader suite of technology solutions to sites, biopharmaceutical companies, and clinical research organizations (CROs) globally, through a site-centric approach, driving increased efficiencies and compliance in clinical trials.
Longboat’s integrated platform helps to simplify trial conduct and participation, increase study compliance, and accelerate clinical trials. Longboat provides study teams with comprehensive oversight of and engagement with sites globally, enabling swift action to keep studies on track. Longboat also gives site staff the tools they need to focus on patient care while maintaining protocol compliance.
For more information, click here.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.